ECIA · Encision Inc
Substantial doubt about the company's ability to continue as a going concern.
“As such, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Nov 13, 2025
Key customers — 11% of receivables (September 30, 2025)
“The accounts receivable balance at September 30, 2025, of $761,947 and at March 31, 2025, of $786,471 included no more than 11% from any one customer.”
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Latest filings
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ECIA
this stock
Encision Inc
|
$194,115 | -91.8% | -0.5% | — | 0.0% |
|
ISRG
Intuitive Surgical Inc
|
$151.44B | -22.2% | +20.5% | 53.0 | 2.1% |
|
BDX
Becton Dickinson & Co
|
$53.98B | — | +8.2% | — | 3.3% |
|
MDLN
Medline Inc.
|
$44.21B | -18.8% | +11.5% | — | 3.1% |
|
ALC
Alcon Inc
|
$34.98B | -8.2% | +10.5% | — | 4.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ECIA | -71.7% | +5650.0% | -97.6% | -93.9% | -91.8% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -71.0% | +5649.9% | -109.8% | -93.4% | -103.6% |